Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fletcher

Showing results (301-310 of 326) with videos related to

Pageof 33
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled TrialAnne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
Cell Death and Differentiation|July 28, 2018
Paracrine signalling during ZEB1-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in lung fibrosisLiudi Yao, Franco Conforti, Charlotte Hill, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2015
Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruptionMeghan K Rothenberger, Brandon F Keele, Stephen W Wietgrefe, et al.
AIDS (London, England)|April 8, 2021
Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settingsTanakorn Apornpong, Beatriz Grinsztejn, Michael Hughes, et al.
Neuro-Oncology|June 11, 2025
Novel GABAAR antagonists target networked gene hubs at the leading-edge in high-grade gliomasChloe Shard, Anya C Jones, Anahita Fouladzadeh, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical TrialKara W Chew, Carlee Moser, Eric S Daar, et al.
JCI Insight|August 8, 2024
Effect of metabolic status on response to SIV infection and antiretroviral therapy in nonhuman primatesGabriela M Webb, Kristin A Sauter, Diana Takahashi, et al.
The New England Journal of Medicine|March 14, 2019
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related TuberculosisSusan Swindells, Ritesh Ramchandani, Amita Gupta, et al.
BMC Cancer|December 2, 2025
Pharmacological targeting and characterization of Voltage-Gated Sodium Channels (VGSCs) expressed in the high-grade glioma microenvironmentEmily V Fletcher, Chloe Shard, Yasmin Boyle, et al.
Microbiology Spectrum|May 18, 2026
Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolutionGregory E Edelstein, Tatum N Sass, Rinki Deo, et al.
Pageof 33

Showing results (301-310 of 326) with videos related to

Sort By:
Pageof 33
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled TrialAnne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
Cell Death and Differentiation|July 28, 2018
Paracrine signalling during ZEB1-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in lung fibrosisLiudi Yao, Franco Conforti, Charlotte Hill, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2015
Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruptionMeghan K Rothenberger, Brandon F Keele, Stephen W Wietgrefe, et al.
AIDS (London, England)|April 8, 2021
Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settingsTanakorn Apornpong, Beatriz Grinsztejn, Michael Hughes, et al.
Neuro-Oncology|June 11, 2025
Novel GABAAR antagonists target networked gene hubs at the leading-edge in high-grade gliomasChloe Shard, Anya C Jones, Anahita Fouladzadeh, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical TrialKara W Chew, Carlee Moser, Eric S Daar, et al.
JCI Insight|August 8, 2024
Effect of metabolic status on response to SIV infection and antiretroviral therapy in nonhuman primatesGabriela M Webb, Kristin A Sauter, Diana Takahashi, et al.
The New England Journal of Medicine|March 14, 2019
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related TuberculosisSusan Swindells, Ritesh Ramchandani, Amita Gupta, et al.
BMC Cancer|December 2, 2025
Pharmacological targeting and characterization of Voltage-Gated Sodium Channels (VGSCs) expressed in the high-grade glioma microenvironmentEmily V Fletcher, Chloe Shard, Yasmin Boyle, et al.
Microbiology Spectrum|May 18, 2026
Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolutionGregory E Edelstein, Tatum N Sass, Rinki Deo, et al.
Pageof 33